Cover Image
市場調查報告書

Laboratorios Farmaceuticos ROVI, S.A.:產品平台分析

Laboratorios Farmaceuticos Rovi, S.A. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 301522
出版日期 內容資訊 英文 25 Pages
訂單完成後即時交付
價格
Back to Top
Laboratorios Farmaceuticos ROVI, S.A.:產品平台分析 Laboratorios Farmaceuticos Rovi, S.A. - Product Pipeline Review - 2015
出版日期: 2015年09月09日 內容資訊: 英文 25 Pages
簡介

Laboratorios Farmaceuticos ROVI, S.A. (ROVI),是提供診斷用品,處方藥、成藥等化學、製藥公司。診斷用品顯影劑及顯影劑輸入設備,主要處方藥使用於骨質疏鬆症和慢性阻塞性肺病、 骨關節炎、冠狀動脈疾病、慢性心臟衰竭等治療。成藥有止汗劑,營養補充品,疼痛緩和用冷/溫敷劑等。

本報告提供Laboratorios Farmaceuticos ROVI, S.A.的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的/作用機製/給藥途徑/分子類型的治療藥的評估、後期階段及中止的計劃相關資訊等。

Laboratorios Farmaceuticos Rovi, S.A.的基本資料

  • Laboratorios Farmaceuticos Rovi, S.A.概要
  • 主要資訊
  • 企業資料

Laboratorios Farmaceuticos ROVI, S.A.:R&D概要

  • 主要的治療範圍

Laboratorios Farmaceuticos ROVI, S.A.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Laboratorios Farmaceuticos ROVI, S.A.:開發中產品概況

  • 最後階段的開發中產品
    • 登記前的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Laboratorios Farmaceuticos ROVI, S.A.:藥物簡介

  • enoxaparin biosimilar
  • risperidone
  • letrozole
  • paliperidone

Laboratorios Farmaceuticos ROVI, S.A.:開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Laboratorios Farmaceuticos ROVI, S.A.:最近的開發平台趨勢

Laboratorios Farmaceuticos ROVI, S.A.:暫停中的計劃

Laboratorios Farmaceuticos ROVI, S.A.:總公司和子公司的所在地

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07567CDB

Summary

Global Markets Direct's, 'Laboratorios Farmaceuticos Rovi, S.A. - Product Pipeline Review - 2015', provides an overview of the Laboratorios Farmaceuticos Rovi, S.A.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Laboratorios Farmaceuticos Rovi, S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Laboratorios Farmaceuticos Rovi, S.A. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Laboratorios Farmaceuticos Rovi, S.A.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Laboratorios Farmaceuticos Rovi, S.A.'s pipeline products

Reasons to buy

  • Evaluate Laboratorios Farmaceuticos Rovi, S.A.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Laboratorios Farmaceuticos Rovi, S.A. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Laboratorios Farmaceuticos Rovi, S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Laboratorios Farmaceuticos Rovi, S.A. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Laboratorios Farmaceuticos Rovi, S.A.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Laboratorios Farmaceuticos Rovi, S.A. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Laboratorios Farmaceuticos Rovi, S.A. Snapshot
    • Laboratorios Farmaceuticos Rovi, S.A. Overview
    • Key Information
    • Key Facts
  • Laboratorios Farmaceuticos Rovi, S.A. - Research and Development Overview
    • Key Therapeutic Areas
  • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products Glance
    • Laboratorios Farmaceuticos Rovi, S.A. - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
    • Laboratorios Farmaceuticos Rovi, S.A. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Laboratorios Farmaceuticos Rovi, S.A. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Laboratorios Farmaceuticos Rovi, S.A. - Drug Profiles
    • enoxaparin biosimilar
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • risperidone
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • letrozole
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • paliperidone
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Analysis
    • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products by Target
    • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products by Route of Administration
    • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products by Molecule Type
    • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products by Mechanism of Action
  • Laboratorios Farmaceuticos Rovi, S.A. - Recent Pipeline Updates
  • Laboratorios Farmaceuticos Rovi, S.A. - Dormant Projects
  • Laboratorios Farmaceuticos Rovi, S.A. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Laboratorios Farmaceuticos Rovi, S.A., Key Information
  • Laboratorios Farmaceuticos Rovi, S.A., Key Facts
  • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Indication, 2015
  • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Stage of Development, 2015
  • Laboratorios Farmaceuticos Rovi, S.A. - Monotherapy Products in Pipeline, 2015
  • Laboratorios Farmaceuticos Rovi, S.A. - Pre-Registration, 2015
  • Laboratorios Farmaceuticos Rovi, S.A. - Phase II, 2015
  • Laboratorios Farmaceuticos Rovi, S.A. - Preclinical, 2015
  • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Target, 2015
  • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Route of Administration, 2015
  • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Molecule Type, 2015
  • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products by Mechanism of Action, 2015
  • Laboratorios Farmaceuticos Rovi, S.A. - Recent Pipeline Updates, 2015
  • Laboratorios Farmaceuticos Rovi, S.A. - Dormant Developmental Projects,2015
  • Laboratorios Farmaceuticos Rovi, S.A., Other Locations
  • Laboratorios Farmaceuticos Rovi, S.A., Subsidiaries

List of Figures

  • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Top 10 Indication, 2015
  • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Stage of Development, 2015
  • Laboratorios Farmaceuticos Rovi, S.A. - Monotherapy Products in Pipeline, 2015
  • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Top 10 Target, 2015
  • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Top 10 Route of Administration, 2015
  • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Top 10 Molecule Type, 2015
  • Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top